{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:08:02Z","timestamp":1778717282677,"version":"3.51.4"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004403","name":"Th\u00fcringer Aufbaubank","doi-asserted-by":"publisher","award":["2022 FGI 0015"],"award-info":[{"award-number":["2022 FGI 0015"]}],"id":[{"id":"10.13039\/501100004403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["316213987 - SFB 1278\/2 PolyTarget"],"award-info":[{"award-number":["316213987 - SFB 1278\/2 PolyTarget"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.bioorg.2024.107470","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T22:38:56Z","timestamp":1716417536000},"page":"107470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Bromo-substituted indirubins for inhibition of protein kinase-mediated signalling involved in inflammatory mediator release in human monocytes"],"prefix":"10.1016","volume":"149","author":[{"given":"Vivien","family":"Bachmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Sch\u00e4del","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Westhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milica","family":"Peri\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fritz","family":"Sch\u00f6mberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexios-Leandros","family":"Skaltsounis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"H\u00f6ppener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatu","family":"Pantsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Vilotijevi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Werz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bioorg.2024.107470_b0005","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1517\/13543776.2015.1019865","article-title":"Indirubin derivatives: a patent review (2010 - present)","volume":"25","author":"Gaboriaud-Kolar","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107470_b0010","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00432-004-0579-2","article-title":"Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine","volume":"130","author":"Eisenbrand","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.bioorg.2024.107470_b0015","first-page":"1381","article-title":"Indirubin relieves inflammatory injury of chondrocytes in a mouse model of osteoarthritis","volume":"42","author":"Chen","year":"2022","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.bioorg.2024.107470_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113652","article-title":"Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship","volume":"223","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107470_b0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1074\/jbc.M002466200","article-title":"Indirubins inhibit glycogen synthase kinase-3 beta and CDK5\/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?","volume":"276","author":"Leclerc","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107470_b0030","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3390\/biom11060777","article-title":"Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential","volume":"11","author":"Schepetkin","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107470_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-016-0447-7","article-title":"Indirubin Inhibits LPS-Induced Inflammation via TLR4 Abrogation Mediated by the NF-kB and MAPK Signaling Pathways","volume":"40","author":"Lai","year":"2017","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107470_b0040","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1007\/s10753-019-01083-1","article-title":"6-Bromoindirubin-3'-Oxime Suppresses LPS-Induced Inflammation via Inhibition of the TLR4\/NF-\u03baB and TLR4\/MAPK Signaling Pathways","volume":"42","author":"Liu","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.bioorg.2024.107470_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114170","article-title":"The indirubin derivative 6-bromoindirubin-3'-glycerol-oxime ether (6BIGOE) potently modulates inflammatory cytokine and prostaglandin release from human monocytes through GSK-3 interference","volume":"180","author":"Czapka","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.bioorg.2024.107470_b0050","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/jm100080z","article-title":"5,5'-substituted indirubin-3'-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity","volume":"53","author":"Choi","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107470_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113112","article-title":"Pharmacological properties of indirubin and its derivatives","volume":"151","author":"Yang","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107470_b0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","article-title":"The glamour and gloom of glycogen synthase kinase-3","volume":"29","author":"Jope","year":"2004","journal-title":"Trends Biochem. Sci"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107470_b0065","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1159\/000356606","article-title":"GSK-3\u03b2 inhibition attenuates LPS-induced death but aggravates radiation-induced death via down-regulation of IL-6","volume":"32","author":"Li","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107470_b0070","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni1221","article-title":"Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3","volume":"6","author":"Martin","year":"2005","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.bioorg.2024.107470_b0075","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1021\/jm401740w","article-title":"Indirubin Core Structure of Glycogen Synthase Kinase-3 Inhibitors as Novel Chemotype for Intervention with 5-Lipoxygenase","volume":"57","author":"Pergola","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107470_b0080","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.phrs.2018.11.035","article-title":"Cyclin-dependent protein serine\/threonine kinase inhibitors as anticancer drugs","volume":"139","author":"Roskoski","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107470_b0085","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/gb4184","article-title":"Cyclin-dependent kinases","volume":"15","author":"Malumbres","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.bioorg.2024.107470_b0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0076-6879(97)83011-X","article-title":"Chemical inhibitors of cyclin-dependent kinases","volume":"283","author":"Meijer","year":"1997","journal-title":"Methods Enzymol."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107470_b0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1054\/bjoc.2000.1546","article-title":"Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells","volume":"84","author":"Marko","year":"2001","journal-title":"Br. J. Cancer"},{"issue":"14","key":"10.1016\/j.bioorg.2024.107470_b0100","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1055\/s-0032-1315261","article-title":"From Tyrian purple to kinase modulators: naturally halogenated indirubins and synthetic analogues","volume":"78","author":"Vougogiannopoulou","year":"2012","journal-title":"Planta Med."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107470_b0105","first-page":"629","article-title":"Synthesis of some halogenated indirubin derivatives","volume":"24","author":"Gu","year":"1989","journal-title":"Yao Xue Xue Bao"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107470_b0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/gtc.12475","article-title":"Mediator cyclin-dependent kinases upregulate transcription of inflammatory genes in cooperation with NF-\u03baB and C\/EBP\u03b2 on stimulation of Toll-like receptor 9","volume":"22","author":"Yamamoto","year":"2017","journal-title":"Genes Cells"},{"issue":"13","key":"10.1016\/j.bioorg.2024.107470_b0115","doi-asserted-by":"crossref","first-page":"8416","DOI":"10.1093\/nar\/gku529","article-title":"ATM regulates NF-\u03baB-dependent immediate-early genes via RelA Ser 276 phosphorylation coupled to CDK9 promoter recruitment","volume":"42","author":"Fang","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2024.107470_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145200","article-title":"Transcriptional cyclin-dependent kinases as the mediators of inflammation-a review","volume":"769","author":"Sundar","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.bioorg.2024.107470_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120301","article-title":"Overview of nanoparticulate strategies for solubility enhancement of poorly soluble drugs","volume":"291","author":"Khan","year":"2022","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107470_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-021-01179-7","article-title":"Drug delivery of 6-bromoindirubin-3\u2019-glycerol-oxime ether employing poly(d, l-lactide-co-glycolide)-based nanoencapsulation techniques with sustainable solvents","volume":"20","author":"Czapka","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"17","key":"10.1016\/j.bioorg.2024.107470_b0135","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1016\/j.bmc.2017.07.009","article-title":"5-Bromoindirubin 3'-(O-oxiran-2-ylmethyl)oxime: A long-acting anticancer agent and a suicide inhibitor for epoxide hydrolase","volume":"25","author":"Ichimaru","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2024.107470_b0140","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1016\/j.bmc.2006.05.036","article-title":"Synthesis of novel 5-substituted indirubins as protein kinases inhibitors","volume":"14","author":"Beauchard","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107470_b0145","unstructured":"Jove RN, Sangkil; Xie, Jun X, US 2015\/0259288, 2015."},{"key":"10.1016\/j.bioorg.2024.107470_b0150","unstructured":"Jove RN, Sangkil; Horne, David; Xie, Jun; Skaltsounis, Alexios Leandros; Kritsanida, Marina; Gaboriaud-Kolar, Nicolas, US11306072B2 5-bromo-indirubins, 2022."},{"issue":"14","key":"10.1016\/j.bioorg.2024.107470_b0155","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1111\/febs.16266","article-title":"Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections","volume":"289","author":"Jordan","year":"2022","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107470_b0160","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016311","article-title":"Lipid mediators in the resolution of inflammation","volume":"7","author":"Serhan","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107470_b0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41467-017-02538-5","article-title":"Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity","volume":"9","author":"Werz","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107470_b0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/156802607779941341","article-title":"Dual acting anti-inflammatory drugs","volume":"7","author":"Leone","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107470_b0175","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13568-020-01107-2","article-title":"Indirubin exerts anticancer effects on human glioma cells by inducing apoptosis and autophagy","volume":"10","author":"Li","year":"2020","journal-title":"AMB Express"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107470_b0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbrc.2017.12.106","article-title":"Indirubin 3'-oxime inhibits anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells","volume":"496","author":"Tanaka","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107470_b0185","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0306-3623(98)00069-X","article-title":"Analogs of staurosporine: potential anticancer drugs?","volume":"31","author":"Gescher","year":"1998","journal-title":"Gen. Pharmacol."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107470_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101148","article-title":"Intracellular Signals Activated by Canonical Wnt Ligands Independent of GSK3 Inhibition and \u03b2-Catenin Stabilization","volume":"8","author":"Garc\u00eda de Herreros","year":"2019","journal-title":"Cells."},{"issue":"6559","key":"10.1016\/j.bioorg.2024.107470_b0195","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bioorg.2024.107470_b0200","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0165-6147(02)02071-0","article-title":"Pharmacological inhibitors of cyclin-dependent kinases","volume":"23","author":"Knockaert","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107470_b0205","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.immuni.2012.10.017","article-title":"CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response","volume":"38","author":"Bancerek","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107470_b0210","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbrc.2019.07.032","article-title":"CDK9 attenuation exerts protective effects on catabolism and hypertrophy in chondrocytes and ameliorates osteoarthritis development","volume":"517","author":"Xue","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107470_b0215","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1021\/acs.jmedchem.5b01685","article-title":"Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19","volume":"59","author":"Mallinger","year":"2016","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107470_b0220","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nchembio.2458","article-title":"Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells","volume":"13","author":"Johannessen","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2024.107470_b0225","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ejmech.2018.09.025","article-title":"Discovery of 4-(((4-(5-chloro-2-(((1s,4s)-4-((2-methoxyethyl)amino)cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor","volume":"158","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107470_b0230","doi-asserted-by":"crossref","unstructured":"Vassilev LT. Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1. PNAS 2006;103((28)):106660-10665.","DOI":"10.1073\/pnas.0600447103"},{"issue":"8","key":"10.1016\/j.bioorg.2024.107470_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23081899","article-title":"Binding Affinity via Docking: Fact and Fiction","volume":"23","author":"Pantsar","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107470_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120404","article-title":"Sustainable preparation of anti-inflammatory atorvastatin PLGA nanoparticles","volume":"599","author":"Grune","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2024.107470_b0245","first-page":"102","article-title":"Sunil Kumar Prajapati, Chand Prakash Jain. Variables Influencing the Drug Entrapment Efficiency of Microspheres","volume":"2","author":"Ram Chand Dhakar","year":"2010","journal-title":"A Pharmaceutical Review. Der Pharmaciaa Lettre."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2024.107470_b0250","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijpharm.2016.12.025","article-title":"Polymeric nanoparticles - Influence of the glass transition temperature on drug release","volume":"517","author":"Lappe","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2024.107470_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105065","article-title":"Impact of drug particle shape on permeability and cellular uptake in the lung","volume":"139","author":"Zellnitz","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107470_b0260","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","article-title":"Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release","volume":"116","author":"Kamaly","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2024.107470_b0265","doi-asserted-by":"crossref","DOI":"10.1080\/00397910903318591","article-title":"Novel synthesis of 4-or 6-substituted indirubin derivatives","author":"Zhang","year":"2010","journal-title":"Synth. Commun."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107470_b9000","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/ol203431e","volume":"14","author":"Nagorny","year":"2012","journal-title":"Org. Lett."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107470_b0270","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1096\/fj.201802509R","article-title":"Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome","volume":"33","author":"Werner","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.bioorg.2024.107470_b0275","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcp.2017.02.004","article-title":"Selective upregulation of TNFalpha expression in classically-activated human monocyte-derived macrophages (M1) through pharmacological interference with V-ATPase","volume":"130","author":"Thomas","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107470_b0280","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12951-020-00620-7","article-title":"Encapsulation of the dual FLAP\/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity","volume":"18","author":"Shkodra-Pula","year":"2020","journal-title":"J Nanobiotechnology."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107470_b0285","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2024.107470_b0290","doi-asserted-by":"crossref","unstructured":"Bowers K, Chow E, Xu H, Dror R, Eastwood M, Gregersen B, et al. Molecular dynamics - Scalable algorithms for molecular dynamics simulations on commodity clusters. Supercomputing, Tampa, FL, USA, 2006, pp. 43-43, doi: 10.1109\/SC.2006.54.","DOI":"10.1109\/SC.2006.54"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107470_b0295","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.chembiol.2003.11.010","article-title":"GSK-3-selective inhibitors derived from Tyrian purple indirubins","volume":"10","author":"Meijer","year":"2003","journal-title":"Chem. Biol."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107470_b0300","doi-asserted-by":"crossref","first-page":"e1000426","DOI":"10.1371\/journal.pbio.1000426","article-title":"Structure of the CaMKIIdelta\/calmodulin complex reveals the molecular mechanism of CaMKII kinase activation","volume":"8","author":"Rellos","year":"2010","journal-title":"PLoS Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107470_b0305","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107470_b0310","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-2836(02)00470-9","article-title":"On the role of the crystal environment in determining protein side-chain conformations","volume":"320","author":"Jacobson","year":"2002","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107470_b0315","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction","volume":"55","author":"Jacobson","year":"2004","journal-title":"Proteins"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107470_b0320","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"issue":"5814","key":"10.1016\/j.bioorg.2024.107470_b0325","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1126\/science.1136800","article-title":"Clustering by passing messages between data points","volume":"315","author":"Frey","year":"2007","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107470_b0330","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107470_b0335","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107470_b0340","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1021\/acs.jmedchem.6b01254","article-title":"Cyclin-Dependent Kinase (CDK) Inhibitors: Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines","volume":"60","author":"Coxon","year":"2017","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107470_b0345","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nchembio.1952","article-title":"A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease","volume":"11","author":"Dale","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107470_b0350","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1021\/jm301495v","article-title":"Comparative structural and functional studies of 4-(thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 inhibitors suggest the basis for isotype selectivity","volume":"56","author":"Hole","year":"2013","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824003754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824003754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:14:00Z","timestamp":1778714040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824003754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":71,"alternative-id":["S0045206824003754"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107470","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bromo-substituted indirubins for inhibition of protein kinase-mediated signalling involved in inflammatory mediator release in human monocytes","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107470"}}